Detalhe da pesquisa
1.
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden.
Blood;
141(21): 2587-2598, 2023 05 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36787509
2.
How I treat refractory/relapsed diffuse large B-cell lymphomas with CD19-directed chimeric antigen receptor T cells.
Br J Haematol;
201(3): 396-410, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36916189
3.
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Blood;
138(25): 2696-2701, 2021 12 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34343258
4.
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Mol Ther;
28(9): 1974-1986, 2020 09 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32526203
5.
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.
Haematologica;
108(1): 290-294, 2023 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35899391
6.
CD47 expression in acute myeloid leukemia varies according to genotype.
Haematologica;
108(12): 3491-3495, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37381766
7.
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma.
Am J Hematol;
98(1): 212-219, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36346356
8.
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML.
Blood Adv;
7(12): 2855-2871, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36521101
9.
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement.
Front Immunol;
13: 934700, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35911683
10.
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Leukemia;
36(10): 2351-2367, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36008542
11.
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.
Cancers (Basel);
13(3)2021 Jan 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33525388
12.
Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax.
EJHaem;
4(2): 559-562, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37206291
13.
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.
Leukemia;
35(11): 3314-3318, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33731847